Proud about PRADA: radiotherapy before deep inferior epigastric perforator flap reconstruction

Affiliations

¹ Breast Radiation Therapy Unit, Sheba Tel Hashomer, Ramat Gan, Israel; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
² Department of Radiation Oncology, Iridium Netwerk, Wilrijk-Antwerpen 2610, Belgium; Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk-Antwerpen, Belgium. Electronic address: philip.poortmans@telenet.be.

Comment

Orit Kaidar-Person et al. Lancet Oncol. 2022 May.

. 2022 May;23(5):560-562.

doi: 10.1016/S1470-2045(22)00195-4. Epub 2022 Apr 7.

¹ Breast Radiation Therapy Unit, Sheba Tel Hashomer, Ramat Gan, Israel; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
² Department of Radiation Oncology, Iridium Netwerk, Wilrijk-Antwerpen 2610, Belgium; Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk-Antwerpen, Belgium. Electronic address: philip.poortmans@telenet.be.

No abstract available

Conflict of interest statement

We declare no competing interests.

Primary radiotherapy and deep inferior epigastric perforator flap reconstruction for patients with breast cancer (PRADA): a multicentre, prospective, non-randomised, feasibility study.
Thiruchelvam PTR, Leff DR, Godden AR, Cleator S, Wood SH, Kirby AM, Jallali N, Somaiah N, Hunter JE, Henry FP, Micha A, O'Connell RL, Mohammed K, Patani N, Tan MLH, Gujral D, Ross G, James SE, Khan AA, Rusby JE, Hadjiminas DJ, MacNeill FA; PRADA Trial Management Group. Thiruchelvam PTR, et al. Lancet Oncol. 2022 May;23(5):682-690. doi: 10.1016/S1470-2045(22)00145-0. Epub 2022 Apr 7. Lancet Oncol. 2022. PMID: 35397804 Free PMC article.